Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor?
- PMID: 32867137
- PMCID: PMC7555654
- DOI: 10.3390/life10090165
Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor?
Abstract
As of January 2020, a new pandemic has spread from Wuhan and caused thousands of deaths worldwide. Several studies have observed a relationship between coronavirus disease (COVID-19) infection and the cardiovascular system with the appearance of myocardial damage, myocarditis, pericarditis, heart failure and various arrhythmic manifestations, as well as an increase in thromboembolic risk. Cardiovascular manifestations have been highlighted especially in older and more fragile patients and in those with multiple cardiovascular risk factors such as cancer, diabetes, obesity and hypertension. In this review, we will examine the cardiac involvement associated with SARS-CoV-2 infection, focusing on the pathophysiological mechanism underlying manifestations and their clinical implication, taking into account the main scientific papers published to date.
Keywords: SARS-CoV-2 infection; cardiovascular system; heart failure; myocardial injury.
Conflict of interest statement
The manuscript has been read and approved by all authors and has not been submitted for publication to other journals. We also declare that we have no conflict of interest in connection with this paper.
Figures




Similar articles
-
Pathogenic mechanisms of cardiovascular damage in COVID-19.Mol Med. 2024 Jun 19;30(1):92. doi: 10.1186/s10020-024-00855-2. Mol Med. 2024. PMID: 38898389 Free PMC article. Review.
-
Cardiovascular impact of COVID-19 with a focus on children: A systematic review.World J Clin Cases. 2020 Nov 6;8(21):5250-5283. doi: 10.12998/wjcc.v8.i21.5250. World J Clin Cases. 2020. PMID: 33269260 Free PMC article.
-
The heart and SARS-CoV-2.Med Clin (Barc). 2022 Nov 11;159(9):440-446. doi: 10.1016/j.medcli.2022.07.002. Epub 2022 Jul 20. Med Clin (Barc). 2022. PMID: 35945062 Free PMC article. Review. English, Spanish.
-
COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations.Aging Dis. 2023 Dec 1;14(6):2071-2088. doi: 10.14336/AD.2023.0314. Aging Dis. 2023. PMID: 37199573 Free PMC article. Review.
-
COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.Curr Med Res Opin. 2022 Jul;38(7):1071-1079. doi: 10.1080/03007995.2022.2078081. Epub 2022 Jun 3. Curr Med Res Opin. 2022. PMID: 35575011 Review.
Cited by
-
COVID-19 and the cardiovascular system-current knowledge and future perspectives.World J Clin Cases. 2022 Sep 26;10(27):9602-9610. doi: 10.12998/wjcc.v10.i27.9602. World J Clin Cases. 2022. PMID: 36186205 Free PMC article. Review.
-
COVID-19 and thyroid function: What do we know so far?Front Endocrinol (Lausanne). 2022 Dec 19;13:1041676. doi: 10.3389/fendo.2022.1041676. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36601011 Free PMC article. Review.
-
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis.Life (Basel). 2024 Feb 26;14(3):305. doi: 10.3390/life14030305. Life (Basel). 2024. PMID: 38541631 Free PMC article. Review.
-
Renal Involvement in COVID-19: A Review of the Literature.Infect Drug Resist. 2021 Mar 5;14:895-903. doi: 10.2147/IDR.S288869. eCollection 2021. Infect Drug Resist. 2021. PMID: 33707958 Free PMC article. Review.
-
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy.Life (Basel). 2021 Apr 16;11(4):347. doi: 10.3390/life11040347. Life (Basel). 2021. PMID: 33923857 Free PMC article.
References
-
- Epidemiology Working Group for NCIP Epidemic Response The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin. J. Epidemiol. 2020;41:145–151. - PubMed
-
- National Health Commission of the People’s Republic of China Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition) [(accessed on 25 July 2020)];2020 Available online: http://kjfy.meetingchina.org/msite/news/show/cn/3337.html.
-
- Sagnelli C., Gentile V., Tirri R., Macera M., Cappabianca S., Ciccia F., Coppola N. Vanvitelli COVID-19 group Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient. J. Infect. 2020 doi: 10.1016/j.jinf.2020.05.043. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous